Total planned funding: $643,367,263
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $130,280,706 |
Nigeria | $122,541,664 |
Uganda | $78,102,028 |
South Africa | $59,891,794 |
Zambia | $57,760,468 |
Tanzania | $42,882,322 |
Ethiopia | $32,500,000 |
Côte d'Ivoire | $23,566,828 |
Rwanda | $20,895,211 |
Botswana | $18,067,000 |
Mozambique | $17,878,262 |
Haiti | $13,196,587 |
Vietnam | $9,435,619 |
Zimbabwe | $6,525,000 |
Namibia | $5,479,596 |
Guyana | $3,575,029 |
Eswatini | $600,000 |
Malawi | $145,000 |
Cambodia | $44,149 |
Organizational Types
Private Contractor | $300,051,239 |
Unknown | $265,117,642 |
NGO | $32,199,998 |
FBO | $16,091,491 |
Implementing Agency | $14,376,825 |
Host Country Government Agency | $9,798,346 |
University | $4,124,263 |
Parastatal | $1,073,626 |
Own Agency | $533,833 |
Other USG Agency | $0 |
Program Areas
Treatment | $643,367,263 |
Budget Codes
HTXD: Treatment: ARV Drugs | $643,367,263 |
Top Partner Programs
Management Sciences for Health:
$11,349,815
View countries